Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET IS EXPECTED TO REACH USD 21.28 BILLION BY 2029 FROM USD 13.39 BILLION IN 2023, GROWING AT A CAGR OF 8.03% DURING THE FORECAST PERIOD.
The Research Antibodies & Reagents Market Size, Share, & Trends Analysis Report By
- Product Type:Reagents
- By Product Type (Media & Sera, Stains & Dyes, Buffers, and Other)
- Antibody
- By Product (Primary and Secondary)
- By Form (Monoclonal and Polyclonal)
- By Source (Rabbit, Mouse, Rat, and Other)
- By Research Area (Oncology, Infectious Diseases, Immunology, Neurobiology, Stem Cell, and Other)
- Technology: ELISA, Flow Cytometry, Western Blotting, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Other
- Application: Proteomics, Drug Development, and Genomics
- End-user: Academic & Research Institutes and Research Labs, Pharma & Biotech Companies, and CROs & CDMOs
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
RESEARCH ANTIBODIES & REAGENTS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2029) | USD 21.28 Billion |
| Market Size (2023) | USD 13.39 Billion |
| CAGR (2023-2029) | 8.03% |
| HISTORIC YEAR | 2020-2022 |
| BASE YEAR | 2023 |
| Forecast Year | 2024-2029 |
| Market Segments | Product Type, Technology, Application, End-user, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | Bio-Rad Laboratories, Bio-Techne, Danaher, F. Hoffmann La-Roche, Merck KgaA, and Thermo Fisher Scientific |
MARKET OVERVIEW
The global research antibodies & reagents market was valued at USD 13.39 billion in 2023 and is expected to reach USD 21.28 billion by 2029, growing at a CAGR of 8.03% during the forecast period. The market is a dynamic and indispensable global life sciences and biotechnology sector. Research antibodies and reagents are vital tools that empower scientists and researchers to delve into the intricacies of biology, unravel the mysteries of diseases, and advance the development of novel therapies.
Research antibodies and reagents are fundamental components of life sciences research, playing a pivotal role in various disciplines, including molecular biology, genomics, proteomics, cell biology, immunology, and drug discovery. These essential tools facilitate the investigation of biomolecules, cellular processes, and disease mechanisms. They enable researchers to detect, quantify, and manipulate specific proteins, nucleic acids, and other biomolecules, serving as the building blocks for scientific inquiry. As a result, they underpin the progress of various industries, such as pharmaceuticals, biotechnology, diagnostics, and academia, by aiding in developing therapies, diagnostics, and scientific knowledge.
MARKET TRENDS & DRIVERS
Growing Demand for Precision Medicine
Life sciences and healthcare have recently witnessed a significant shift towards precision medicine. This transformative approach to healthcare promises tailored individualized treatments based on a patient's unique genetic makeup, lifestyle, and environmental factors. Precision medicine can revolutionize disease diagnosis and treatment, making therapies more effective, reducing adverse effects, and improving patient outcomes. This paradigm shift presents a substantial opportunity for the research antibodies & reagents market, an essential component of precision medicine research. Further, precision medicine is characterized by the personalization of medical care. It leverages genetic and molecular information to tailor treatments to individual patients instead of a one-size-fits-all approach. This approach is becoming increasingly important, especially in the treatment of complex and genetically diverse diseases, such as cancer, cardiovascular disorders, and neurodegenerative conditions.
Rising Focus on Biomarker Discovery
Biomarker discovery has emerged as a dynamic and transformative trend within the research antibodies & reagents market. Biomarkers are biological molecules that offer critical insights into various aspects of health and disease. These molecules can include proteins, genes, metabolites, or other molecular indicators that provide valuable information about the body's physiological and pathological conditions. As the understanding of the role of biomarkers in research, diagnostics, and personalized medicine deepens, there is a growing focus on their discovery and application, reshaping the research antibodies & reagents market. Biomarkers are invaluable for the early and accurate diagnosis of diseases. They enable healthcare professionals to identify specific conditions and customize treatment plans.
Increase in Research Academies and Industry Collaborations
The life sciences and biotechnology field is amidst a revolutionary transformation, and the research antibodies & reagents market is at the heart of this change. The demand for high-quality research antibodies and reagents has increased significantly with the emphasis on precision medicine, personalized therapeutics, and advanced diagnostics. The growing collaboration between research academies and the biotechnology industry is a notable driving force behind this surge. Further, collaboration between research academies, such as universities and academic institutions, and the biotechnology industry has become a cornerstone of modern scientific progress. These partnerships bridge the gap between fundamental research and practical applications, ensuring that scientific discoveries are translated into tangible solutions for healthcare and other industries. In the context of research antibodies and reagents, these collaborations yield remarkable results.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT TYPE
The reagents product type accounted for the largest global research antibodies & reagents market share in 2023. Research reagents, often referred to as research materials or laboratory reagents, are the unsung heroes of scientific investigation. They are the critical components that enable researchers, scientists, and investigators to unlock the natural world's mysteries. The demand for research antibodies and reagents has witnessed a significant upswing in recent years, driven by the expanding scope of life sciences research, advancements in personalized medicine, and an increasing emphasis on understanding complex biological processes. These critical tools are integral to various applications, including immunology, cell biology, molecular biology, and genomics.
Ongoing technological advancements in antibody development and reagent manufacturing contribute to the diversification and improvement of research tools. The role of research antibodies and reagents in diagnostics has expanded, with applications ranging from immunoassays for disease detection to the development of diagnostic imaging agents. Collaborations between academic institutions, research organizations, and pharmaceutical companies have intensified. These partnerships drive collaborative research projects, creating a sustained demand for high-quality antibodies and reagents across various research domains.
INSIGHTS BY TECHNOLOGY
The global research antibodies & reagents market by technology is segmented into ELISA, flow cytometry, western blotting, immunofluorescence, immunohistochemistry, immunoprecipitation, and others. In 2023, the ELISA accounted for the most significant share of the global market. ELISA is a powerful and versatile biochemical technique used to quantify and detect specific proteins, antigens, antibodies, and other biomolecules. It has become an indispensable tool for researchers, diagnostic laboratories, and the biotechnology industry, contributing significantly to life sciences and healthcare advancements. Over the years, ELISA has evolved and diversified, leading to various ELISA assays, including direct, indirect, sandwich, and competitive ELISAs. This versatility has made ELISA a fundamental technique in biomedical research. Further, western blotting technology is expected to register the highest CAGR in the research antibodies & reagents industry during the forecast period. Western blotting is a versatile and pivotal method and is often called immunoblotting. It is a powerful tool for detecting and quantifying specific proteins within complex biological samples.
INSIGHTS BY APPLICATION
The global research antibodies & reagents market by application is segmented into proteomics, drug development, and genomics. In 2023, the proteomics application segment accounted for the major share of the global market. Proteomics is a rapidly evolving field of scientific research focusing on the comprehensive study of proteins, their functions, and interactions within a biological system. It plays a pivotal role in understanding the molecular mechanisms of various diseases and has significant applications in drug development, diagnostics, and personalized medicine. The tools and technologies used in proteomics research, such as antibodies and reagents, have become integral components of the scientific toolbox. Also, the proteomics segment is expected to register the highest segmental CAGR in the global research antibodies & reagents market during the forecast period. Further, drug development relies heavily on understanding molecular targets, pathways, and interactions. Research antibodies and reagents are integral to drug discovery and development, contributing to target identification, validation, and preclinical and clinical studies. Antibodies and reagents in genomics applications contribute to understanding gene expression, regulation, and the functional elements within the genome.
INSIGHTS BY END-USER
The academics & research institutes and research labs end-user segment dominated the global research antibodies & reagents market share in 2023. Academics & research institutes play a pivotal role in advancing scientific knowledge. These institutions are engaged in fundamental research across various disciplines, including biology, chemistry, medicine, and environmental sciences. Research antibodies and reagents are pivotal components of life sciences research, enabling the detection and analysis of specific molecules, proteins, or genes within biological samples. These tools are indispensable for various applications, including immunohistochemistry, flow cytometry, Western blotting, and various other assays. Further, the pharmaceutical and biotech sectors often require high throughput screening capabilities, driving the demand for antibodies and reagents suitable for large-scale experiments. CROs and CDMOs provide outsourced research, development, and manufacturing services to the pharmaceutical and biotechnology industries.
GEOGRAPHICAL ANALYSIS
North America holds the most prominent share of the global research antibodies & reagents market, accounting for over 39% in 2023. The U.S. and Canada are major contributors to the North American market. The region boasts advanced healthcare infrastructure, extensive research activities, and a high demand for antibodies and reagents. The regional market is characterized by its dynamic nature, driven by a relentless pursuit of scientific innovation and the need for high-quality tools in life sciences research. North America boasts a thriving ecosystem of key market players, including renowned companies such as Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, and BD Biosciences. These companies are at the forefront of research and development, constantly introducing cutting-edge antibodies and reagents to meet the evolving demands of the scientific community.
The APAC is expected to register the highest CAGR in the global research antibodies & reagents market during the forecast period. The APAC region is experiencing a surge in research activities across various scientific disciplines. Academic institutions, research organizations, and biotechnology companies actively engage in cutting-edge research, driving the demand for high-quality research antibodies and reagents. APAC countries' biotechnology and pharmaceutical sectors, including China, India, Japan, and South Korea, have grown significantly. This expansion is fueled by investments in research and development, leading to an increased demand for antibodies and reagents for drug discovery, development, and validation.
VENDOR LANDSCAPE
The global research antibodies & reagents market has witnessed significant growth, driven by increasing investment in life sciences research, advancements in personalized medicine, and a growing focus on understanding molecular and cellular processes. The rising demand for reliable and high-quality antibodies and reagents is a key factor shaping market dynamics. Furthermore, continuous technological advancements in antibody development and reagent manufacturing contribute to product innovation. Companies investing in research and development to enhance the specificity, sensitivity, and versatility of their products gain a competitive edge in meeting the evolving needs of researchers.
The key global research antibodies & reagents market players are Bio-Rad Laboratories, Bio-Techne, Danaher, F. Hoffmann La-Roche, Merck KgaA, and Thermo Fisher Scientific. One of the prominent market companies, Bio-Rad Laboratories provides a broad spectrum of antibodies, ELISA kits, protein purification tools, western blotting reagents, and other research essentials. This diversity caters to various research areas, from immunology and cell biology to gene expression and protein analysis. The company collaborates with leading academic institutions and other industry players to develop novel antibodies and reagents and enhance existing solutions. The company’s partnership with Lunaphore in 2023 aims to develop the first fully automated spatial multi-omics workflow, a groundbreaking advancement in analyzing proteins and RNA on the same slide. The company has a strong global presence with a network of distributors and direct sales teams, ensuring the accessibility of its products for researchers worldwide.
Frequently Asked Questions
How big is the research antibodies & reagents market?
What is the growth rate of the global research antibodies & reagents market?
Which region dominates the global research antibodies & reagents market share?
What are the significant trends in the research antibodies & reagents industry?
Who are the key players in the global research antibodies & reagents market?
The global research antibodies & reagents market size is expected to grow at a CAGR of approximately 8.03% from 2023 to 2029.
The following factors are likely to contribute to the growth of the research antibodies & reagents market during the forecast period:
- Increase in Research Academies and Industry Collaborations
- Growing R&D and Research Funding for Antibodies Development
- Rise in Proteomics and Genomics Research
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the research antibodies & reagents market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Company Profiles
- Bio-Rad Laboratories
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- Bio-Techne
- Danaher
- F.Hoffmann La-Roche
- Merck KGaA
- Thermo Fisher Scientific
Other Prominent Vendors
- Abcepta
- Business Overview
- Product Offerings
- Abclonal
- Abnova
- Atlas Antibodies
- Aviva Systems Biology
- Cell Signaling Technology
- Cantata Bio
- Fujirebio
- GeneTex
- GenScript
- ICL
- Jackson ImmunoResearch
- MBL International
- Omega Bio-tek
- Proteintech Group
- RayBiotech Life
- ROCKLAND IMMUNOCHEMICALS
- Santa Cruz Biotechnology
- SOL Group
- SouthernBiotech
Segmentation by Product Type
- Reagents
- By Product Type
- Media & Sera
- Stains & Dyes
- Buffers
- Other
- Antibody
- By Product
- Primary
- Secondary
- By Form
- Monoclonal
- Polyclonal
- By Source
- Rabbit
- Mouse
- Rat
- Other
- By Research Area
- Oncology
- Infectious Diseases
- Immunology
- Neurobiology
- Stem Cell
- Other
Segmentation by Technology
- ELISA
- Flow Cytometry
- Western Blotting
- Immunofluorescence
- Immunohistochemistry
- Immunoprecipitation
- Other
Segmentation by Application
- Proteomics
- Drug Development
- Genomics
Segmentation by End-user
- Academic & Research Institutes and Research Labs
- Pharma & Biotech Companies
- CROs & CDMOs
Segmentation by Geography
- North AmericaThe U.S.
- Canada
- EuropeGermany
- The U.K.
- France
- Italy
- Spain
- Russia
- Netherlands
- APACChina
- Japan
- India
- South Korea
- Australia
- Latin AmericaBrazil
- Mexico
- Argentina
- Colombia
- Middle East & AfricaTurkey
- South Africa
- Saudi Arabia
- UAE
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023 & 2029 (% SHARE)
EXHIBIT 3 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023 & 2029 (% SHARE)
EXHIBIT 4 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023 & 2029 (% SHARE)
EXHIBIT 5 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023 & 2029 (% SHARE)
EXHIBIT 6 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023 & 2029 (% SHARE)
EXHIBIT 7 IMPACT OF GROWING DEMAND FOR PRECISION MEDICINE
EXHIBIT 8 IMPACT OF INCREASING OUTSOURCING SERVICES TO CROS & CDMOS
EXHIBIT 9 IMPACT OF GROWING STEM CELLS AND NEUROBIOLOGY RESEARCH
EXHIBIT 10 IMPACT OF RISING FOCUS ON BIOMARKER DISCOVERY
EXHIBIT 11 IMPACT OF INCREASE IN RESEARCH ACADEMIES AND INDUSTRY COLLABORATIONS
EXHIBIT 12 IMPACT OF GROWING R&D AND RESEARCH FUNDING FOR ANTIBODIES DEVELOPMENT
EXHIBIT 13 IMPACT OF RISE IN PROTEOMICS AND GENOMICS RESEARCH
EXHIBIT 14 IMPACT OF QUALITY CONCERNS ASSOCIATED WITH RESEARCH ANTIBODIES & REAGENTS
EXHIBIT 15 IMPACT OF COMPLEXITIES ASSOCIATED WITH METHOD OF ANTIBODY PRODUCTION
EXHIBIT 16 IMPACT OF CHALLENGES ASSOCIATED WITH ALL RESEARCH ACTIVITIES
EXHIBIT 17 IMPACT OF ETHICAL & REGULATORY ISSUES ASSOCIATED WITH ANIMAL-DERIVED MATERIALS AND REAGENTS
EXHIBIT 18 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 19 FIVE FORCES ANALYSIS 2023
EXHIBIT 20 INCREMENTAL GROWTH BY PRODUCT 2023 & 2029
EXHIBIT 21 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT: INCREMENTAL GROWTH 2023-2029 ($ MILLION)
EXHIBIT 22 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT: ABSOLUTE GROWTH 2023–2029 (%)
EXHIBIT 23 GLOBAL RESEARCH REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 24 GLOBAL RESEARCH REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 25 GLOBAL MEDIA & SERA RESEARCH REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 26 GLOBAL MEDIA & SERA RESEARCH REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 27 GLOBAL STAINS & DYES RESEARCH REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 28 GLOBAL STAINS & DYES RESEARCH REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 29 GLOBAL BUFFERS RESEARCH REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 30 GLOBAL BUFFERS RESEARCH REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 31 GLOBAL OTHER RESEARCH REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 32 GLOBAL OTHER RESEARCH REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 33 GLOBAL RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 35 GLOBAL PRIMARY RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL PRIMARY RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 37 GLOBAL SECONDARY RESEARCH ANTIBODIES MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 38 GLOBAL SECONDARY RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 39 GLOBAL MONOCLONAL RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL MONOCLONAL RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 41 GLOBAL POLYCLONAL RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL POLYCLONAL RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 43 GLOBAL RABBIT RESEARCH ANTIBODIES MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 44 GLOBAL RABBIT RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 45 GLOBAL MOUSE RESEARCH ANTIBODIES MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 46 GLOBAL MOUSE RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 47 GLOBAL RAT RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL RAT RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 49 GLOBAL OTHER RESEARCH ANTIBODIES MARKET: INCREMENTAL & ABSOLUTE GROWTH 2023–2029
EXHIBIT 50 GLOBAL OTHER RESEARCH ANTIBODIES MARKET 2023–2029 ($ MILLION)
EXHIBIT 51 GLOBAL ONCOLOGY RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL ONCOLOGY RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 53 GLOBAL INFECTIOUS DISEASES RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL INFECTIOUS DISEASES RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 55 GLOBAL IMMUNOLOGY RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL IMMUNOLOGY RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 57 GLOBAL NEUROBIOLOGY RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL NEUROBIOLOGY RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 59 GLOBAL STEM CELL RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL STEM CELL RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 61 GLOBAL OTHER RESEARCH ANTIBODIES MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL OTHER RESEARCH ANTIBODIES MARKET 2020–2029 ($ MILLION)
EXHIBIT 63 INCREMENTAL GROWTH BY TECHNOLOGY 2023 & 2029
EXHIBIT 64 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023–2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 65 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023–2029: ABSOLUTE GROWTH (%)
EXHIBIT 66 GLOBAL ELISA RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL ELISA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 68 GLOBAL FLOW CYTOMETRY RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL FLOW CYTOMETRY RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 70 GLOBAL WESTERN BLOTTING RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 71 GLOBAL WESTERN BLOTTING RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 72 GLOBAL IMMUNOFLUORESCENCE RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL IMMUNOFLUORESCENCE RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 74 GLOBAL IMMUNOHISTOCHEMISTRY RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 GLOBAL IMMUNOHISTOCHEMISTRY RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 76 GLOBAL IMMUNOPRECIPITATION RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL IMMUNOPRECIPITATION RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 78 GLOBAL OTHER RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 79 GLOBAL OTHER RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 80 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
EXHIBIT 81 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023–2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 82 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023–2029: ABSOLUTE GROWTH (%)
EXHIBIT 83 GLOBAL PROTEOMICS RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 84 GLOBAL PROTEOMICS RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 85 GLOBAL DRUG DEVELOPMENT RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 86 GLOBAL DRUG DEVELOPMENT RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 87 GLOBAL GENOMICS RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 88 GLOBAL GENOMICS RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 89 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 90 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023–2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 91 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023–2029: ABSOLUTE GROWTH (%)
EXHIBIT 92 GLOBAL ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 93 GLOBAL ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 94 GLOBAL PHARMA & BIOTECH COMPANIES RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 95 GLOBAL PHARMA & BIOTECH COMPANIES RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 96 GLOBAL CROS & CDMOS RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 97 GLOBAL CROS & CDMOS RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 98 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 99 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023–2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 100 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023–2029: ABSOLUTE GROWTH (%)
EXHIBIT 101 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 102 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 103 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 104 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 105 US LABORATORY TYPES AND TEST VOLUMES
EXHIBIT 106 US RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 107 CANADA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 108 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 109 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 110 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 111 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 112 GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 113 UK RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029 ($ MILLION)
EXHIBIT 114 FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029 ($ MILLION)
EXHIBIT 115 ITALY RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 116 SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 117 RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 118 NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 119 APAC RESEARCH ANTIBODIES & REAGENTS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 120 APAC RESEARCH ANTIBODIES & REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 121 APAC RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 122 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 123 CHINA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 124 JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 125 INDIA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 126 SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029 ($ MILLION)
EXHIBIT 127 AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 128 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 129 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 130 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029 ($ MILLION)
EXHIBIT 131 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 132 BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 133 MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 134 ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET 2023–2029 ($ MILLION)
EXHIBIT 135 COLOMBIA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 136 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET: KEY COUNTRIES IN 2023
EXHIBIT 137 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 138 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 139 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 140 TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 141 SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 142 SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 143 UAE RESEARCH ANTIBODIES & REAGENTS MARKET 2020–2029 ($ MILLION)
EXHIBIT 144 VENDORS OFFERING RESEARCH ANTIBODIES & REAGENTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 145 VENDORS OFFERING COMMERCIAL RESEARCH ANTIBODIES & REAGENTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 146 KEY CAVEATS
LIST OF TABLES
TABLE 1 GLOBAL RESEARCH REAGENTS MARKET BY PRODUCT 2023−2029 ($ MILLION)
TABLE 2 GLOBAL RESEARCH REAGENTS MARKET BY PRODUCT 2023−2029 (% SHARE)
TABLE 3 GLOBAL RESEARCH REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 4 GLOBAL RESEARCH REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 5 GLOBAL RESEARCH ANTIBODIES MARKET BY ANTIBODY TYPE 2023−2029 ($ MILLION)
TABLE 6 GLOBAL RESEARCH ANTIBODIES MARKET BY ANTIBODY TYPE 2023−2029 (%)
TABLE 7 GLOBAL RESEARCH ANTIBODIES MARKET BY FORM 2023−2029 ($ MILLION)
TABLE 8 GLOBAL RESEARCH ANTIBODIES MARKET BY FORM 2023−2029 (% SHARE)
TABLE 9 GLOBAL RESEARCH ANTIBODIES MARKET BY SOURCE 2023−2029 ($ MILLION)
TABLE 10 GLOBAL RESEARCH ANTIBODIES MARKET BY SOURCE 2023−2029 (%)
TABLE 11 GLOBAL RESEARCH ANTIBODIES MARKET BY RESEARCH AREA 2023−2029 ($ MILLION)
TABLE 12 GLOBAL RESEARCH ANTIBODIES MARKET BY RESEARCH AREA 2023−2029 (%)
TABLE 13 GLOBAL ANTIBODY REAGENTS RESEARCH ANTIBODIES &REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 14 GLOBAL ANTIBODY REAGENTS RESEARCH ANTIBODIES &REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 15 GLOBAL ELISA RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 16 GLOBAL ELISA RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 17 GLOBAL FLOW CYTOMETRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 18 GLOBAL FLOW CYTOMETRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 19 GLOBAL WESTERN BLOTTING RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 20 GLOBAL WESTERN BLOTTING RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 21 GLOBAL IMMUNOFLUORESCENCE RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 22 GLOBAL IMMUNOFLUORESCENCE RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 23 GLOBAL IMMUNOHISTOCHEMISTRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 24 GLOBAL IMMUNOHISTOCHEMISTRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 25 GLOBAL IMMUNOPRECIPITATION RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 26 GLOBAL IMMUNOPRECIPITATION RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 27 GLOBAL OTHER RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 28 GLOBAL OTHER RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 29 GLOBAL PROTEOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 30 GLOBAL PROTEOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 31 GLOBAL DRUG DEVELOPMENT RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 32 GLOBAL DRUG DEVELOPMENT RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 33 GLOBAL GENOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 34 GLOBAL GENOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 35 GLOBAL ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 36 GLOBAL ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 37 GLOBAL PHARMA & BIOTECH COMPANIES RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 38 GLOBAL PHARMA & BIOTECH COMPANIES RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 39 GLOBAL CROS & CDMOS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 40 GLOBAL CROS & CDMOS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 41 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT 2023−2029 ($ MILLION)
TABLE 42 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 43 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 44 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 45 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 46 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 47 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 48 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 49 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 50 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 51 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 52 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 53 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 54 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 55 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 56 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 57 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 58 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 59 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 60 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 61 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 62 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 63 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 64 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 65 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 66 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 67 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 68 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 69 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 70 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 71 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 72 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 73 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 74 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 75 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 76 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 77 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 78 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 79 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 80 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 81 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 82 BIO-TECHNE: MAJOR PRODUCT OFFERINGS
TABLE 83 DANAHER: MAJOR PRODUCT OFFERINGS
TABLE 84 F. HOFFMANN LA-ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 85 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 86 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 87 ABCEPTA: MAJOR PRODUCT OFFERINGS
TABLE 88 ABCLONAL: MAJOR PRODUCT OFFERINGS
TABLE 89 ABNOVA: MAJOR PRODUCT OFFERINGS
TABLE 90 ATLAS ANTIBODIES: MAJOR PRODUCT OFFERINGS
TABLE 91 AVIVA SYSTEMS BIOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 92 CELL SIGNALING TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 93 CANTATA BIO: MAJOR PRODUCT OFFERINGS
TABLE 94 FUJIREBIO: MAJOR PRODUCT OFFERINGS
TABLE 95 GENETEX: MAJOR PRODUCT OFFERINGS
TABLE 96 GENSCRIPT: MAJOR PRODUCT OFFERINGS
TABLE 97 ICL: MAJOR PRODUCT OFFERINGS
TABLE 98 JACKSON IMMUNORESEARCH: MAJOR PRODUCT OFFERINGS
TABLE 99 MBL INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 100 OMEGA BIO-TEK: MAJOR PRODUCT OFFERINGS
TABLE 101 PROTEINTECH GROUP: MAJOR PRODUCT OFFERINGS
TABLE 102 RAYBIOTECH LIFE: MAJOR PRODUCT OFFERINGS
TABLE 103 ROCKLAND IMMUNOCHEMICALS: MAJOR PRODUCT OFFERINGS
TABLE 104 SANTA CRUZ BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 105 SOL GROUP: MAJOR PRODUCT OFFERINGS
TABLE 106 SOUTHERNBIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 107 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 108 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 109 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 110 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 111 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 112 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 113 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 114 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 115 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 116 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 117 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 118 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 119 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 120 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 121 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 122 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 123 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 124 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 125 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 126 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 127 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 128 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 129 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 130 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 131 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 132 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 133 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 134 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 135 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 136 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 137 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 138 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 139 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 140 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 141 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 142 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY APPLICATION 2023−2029 (%)
TABLE 143 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 144 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 145 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 146 NORTH AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 147 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 148 EUROPE RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 149 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 150 APAC RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 151 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 152 LATIN AMERICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 153 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 154 MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET BY END-USER 2023−2029 (%)
TABLE 155 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 156 GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 157 GLOBAL RESEARCH REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 158 GLOBAL RESEARCH REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 159 GLOBAL RESEARCH ANTIBODIES MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 160 GLOBAL RESEARCH ANTIBODIES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 161 GLOBAL ELISA RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 162 GLOBAL ELISA RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 163 GLOBAL FLOW CYTOMETRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 164 GLOBAL FLOW CYTOMETRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 165 GLOBAL WESTERN BLOTTING RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 166 GLOBAL WESTERN BLOTTING RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 167 GLOBAL IMMUNOFLUORESCENCE RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 168 GLOBAL IMMUNOFLUORESCENCE RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 169 GLOBAL IMMUNOHISTOCHEMISTRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 170 GLOBAL IMMUNOHISTOCHEMISTRY RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 171 GLOBAL IMMUNOPRECIPITATION RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 172 GLOBAL IMMUNOPRECIPITATION RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 173 GLOBAL OTHER RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 174 GLOBAL OTHER RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 175 GLOBAL PROTEOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 176 GLOBAL PROTEOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 177 GLOBAL DRUG DEVELOPMENT RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 178 GLOBAL DRUG DEVELOPMENT RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 179 GLOBAL GENOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 180 GLOBAL GENOMICS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 181 GLOBAL ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 182 GLOBAL ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 183 GLOBAL PHARMA & BIOTECH COMPANIES RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 184 GLOBAL PHARMA & BIOTECH COMPANIES RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 185 GLOBAL CROS & CDMOS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 186 GLOBAL CROS & CDMOS RESEARCH ANTIBODIES & REAGENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 187 CURRENCY CONVERSION 2017−2023
1 SCOPE & COVERAGE
1.1 MARKET DEFINITION
1.1.1 INCLUSIONS
1.1.2 EXCLUSIONS
1.1.3 MARKET ESTIMATION CAVEATS
1.2 MARKET SEGMENTATION
1.2.1 MARKET BY PRODUCT
1.2.2 MARKET BY TECHNOLOGY
1.2.3 MARKET BY APPLICATION
1.2.4 MARKET BY END-USER
1.3 REGIONS & COUNTRIES COVERED
1.4 BASE YEAR
1.5 MARKET DERIVATION
2 PREMIUM INSIGHTS
2.1 OPPORTUNITY POCKETS
2.2 OVERVIEW
2.2.1 GEOGRAPHY INSIGHTS
2.2.2 PRODUCT TYPE INSIGHTS
2.2.3 TECHNOLOGY INSIGHTS
2.2.4 APPLICATION INSIGHTS
2.2.5 END-USER INSIGHTS
3 MARKET AT A GLANCE
4 INTRODUCTION
4.1 OVERVIEW
4.1.1 RESEARCH ANTIBODIES
4.1.2 RESEARCH REAGENTS
5 MARKET OPPORTUNITIES & TRENDS
5.1 GROWING DEMAND FOR PRECISION MEDICINE
5.2 INCREASING OUTSOURCING SERVICES TO CROS & CDMOS
5.3 GROWING STEM CELLS AND NEUROBIOLOGY RESEARCH
5.4 RISING FOCUS ON BIOMARKER DISCOVERY
6 MARKET GROWTH ENABLERS
6.1 INCREASE IN RESEARCH ACADEMIES AND INDUSTRY COLLABORATIONS
6.2 GROWING R&D AND RESEARCH FUNDING FOR ANTIBODY DEVELOPMENT
6.3 RISE IN PROTEOMICS AND GENOMICS RESEARCH
7 MARKET RESTRAINTS
7.1 QUALITY CONCERNS ASSOCIATED WITH RESEARCH ANTIBODIES & REAGENTS
7.2 COMPLEXITIES ASSOCIATED WITH METHOD OF ANTIBODY PRODUCTION
7.3 CHALLENGES ASSOCIATED WITH ALL RESEARCH ACTIVITIES
7.4 ETHICAL & REGULATORY ISSUES ASSOCIATED WITH ANIMAL-DERIVED MATERIALS AND REAGENTS
8 MARKET LANDSCAPE
8.1 MARKET OVERVIEW
8.2 MARKET SIZE & FORECAST
8.3 FIVE FORCES ANALYSIS
8.3.1 THREAT OF NEW ENTRANTS
8.3.2 BARGAINING POWER OF SUPPLIERS
8.3.3 BARGAINING POWER OF BUYERS
8.3.4 THREAT OF SUBSTITUTES
8.3.5 COMPETITIVE RIVALRY
9 PRODUCT
9.1 MARKET SNAPSHOT & GROWTH ENGINE
9.2 MARKET OVERVIEW
10 REAGENTS
10.1 MARKET OVERVIEW
10.2 MARKET SIZE & FORECAST
10.3 REAGENTS: PRODUCT SEGMENTATION
10.3.1 REAGENTS MARKET BY PRODUCT
10.3.2 MEDIA & SERA: MARKET SIZE & FORECAST
10.3.3 STAINS & DYES: MARKET SIZE & FORECAST
10.3.4 BUFFERS: MARKET SIZE & FORECAST
10.3.5 OTHERS: MARKET SIZE & FORECAST
10.3.6 REAGENTS MARKET BY GEOGRAPHY
11 ANTIBODY
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.3 ANTIBODIES: PRODUCT
11.3.1 RESEARCH ANTIBODIES MARKET BY ANTIBODY TYPE
11.3.2 PRIMARY ANTIBODY: MARKET SIZE & FORECAST
11.3.3 SECONDARY ANTIBODY: MARKET SIZE & FORECAST
11.4 ANTIBODIES: FORM
11.4.1 RESEARCH ANTIBODIES MARKET BY FORM
11.4.2 MONOCLONAL ANTIBODY: MARKET SIZE & FORECAST
11.4.3 POLYCLONAL ANTIBODY: MARKET SIZE & FORECAST
11.5 ANTIBODIES: SOURCE
11.5.1 RESEARCH ANTIBODIES MARKET BY SOURCE
11.5.2 RABBIT: MARKET SIZE & FORECAST
11.5.3 MOUSE: MARKET SIZE & FORECAST
11.5.4 RAT: MARKET SIZE & FORECAST
11.5.5 OTHER: MARKET SIZE & FORECAST
11.6 RESEARCH AREA
11.6.1 ONCOLOGY: MARKET SIZE & FORECAST
11.6.2 INFECTIOUS DISEASES: MARKET SIZE & FORECAST
11.6.3 IMMUNOLOGY: MARKET SIZE & FORECAST
11.6.4 NEUROBIOLOGY: MARKET SIZE & FORECAST
11.6.5 STEM CELL: MARKET SIZE & FORECAST
11.6.6 OTHER: MARKET SIZE & FORECAST
11.6.7 RESEARCH ANTIBODIES MARKET BY RESEARCH AREA
11.6.8 ANTIBODY MARKET BY GEOGRAPHY
12 TECHNOLOGY
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 ELISA
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 ELISA MARKET BY GEOGRAPHY
12.4 FLOW CYTOMETRY
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 FLOW CYTOMETRY MARKET BY GEOGRAPHY
12.5 WESTERN BLOTTING
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 WESTERN BLOTTING MARKET BY GEOGRAPHY
12.6 IMMUNOFLUORESCENCE
12.6.1 MARKET OVERVIEW
12.6.2 MARKET SIZE & FORECAST
12.6.3 IMMUNOFLUORESCENCE MARKET BY GEOGRAPHY
12.7 IMMUNOHISTOCHEMISTRY
12.7.1 MARKET OVERVIEW
12.7.2 MARKET SIZE & FORECAST
12.7.3 IMMUNOHISTOCHEMISTRY MARKET BY GEOGRAPHY
12.8 IMMUNOPRECIPITATION
12.8.1 MARKET OVERVIEW
12.8.2 MARKET SIZE & FORECAST
12.8.3 IMMUNOPRECIPITATION MARKET BY GEOGRAPHY
12.9 OTHER
12.9.1 MARKET OVERVIEW
12.9.2 MARKET SIZE & FORECAST
12.9.3 OTHER MARKET BY GEOGRAPHY
13 APPLICATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PROTEOMICS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 PROTEOMICS MARKET BY GEOGRAPHY
13.4 DRUG DEVELOPMENT
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 DRUG DEVELOPMENT MARKET BY GEOGRAPHY
13.5 GENOMICS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 GENOMICS MARKET BY GEOGRAPHY
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS MARKET BY GEOGRAPHY
14.4 PHARMA & BIOTECH COMPANIES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 PHARMA & BIOTECH COMPANIES MARKET BY GEOGRAPHY
14.5 CROS & CDMOS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 CROS & CDMOS MARKET BY GEOGRAPHY
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.2.1 NORTH AMERICA MARKET BY PRODUCT TYPE
16.2.2 NORTH AMERICA MARKET BY TECHNOLOGY
16.2.3 NORTH AMERICA MARKET BY APPLICATION
16.2.4 NORTH AMERICA MARKET BY END-USER
16.3 KEY COUNTRIES
16.3.1 US: MARKET SIZE & FORECAST
16.3.2 CANADA: MARKET SIZE & FORECAST
17 EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 EUROPE MARKET BY PRODUCT TYPE
17.2.2 EUROPE MARKET BY TECHNOLOGY
17.2.3 EUROPE MARKET BY APPLICATION
17.2.4 EUROPE MARKET BY END-USER
17.3 KEY COUNTRIES
17.3.1 GERMANY: MARKET SIZE & FORECAST
17.3.2 UK: MARKET SIZE & FORECAST
17.3.3 FRANCE: MARKET SIZE & FORECAST
17.3.4 ITALY: MARKET SIZE & FORECAST
17.3.5 SPAIN: MARKET SIZE & FORECAST
17.3.6 RUSSIA: MARKET SIZE & FORECAST
17.3.7 NETHERLANDS: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 APAC MARKET BY PRODUCT TYPE
18.2.2 APAC MARKET BY TECHNOLOGY
18.2.3 APAC MARKET BY APPLICATION
18.2.4 APAC MARKET BY END-USER
18.3 KEY COUNTRIES
18.3.1 CHINA: MARKET SIZE & FORECAST
18.3.2 JAPAN: MARKET SIZE & FORECAST
18.3.3 INDIA: MARKET SIZE & FORECAST
18.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
18.3.5 AUSTRALIA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 LATIN AMERICA MARKET BY PRODUCT TYPE
19.2.2 LATIN AMERICA MARKET BY TECHNOLOGY
19.2.3 LATIN AMERICA MARKET BY APPLICATION
19.2.4 LATIN AMERICA MARKET BY END-USER
19.3 KEY COUNTRIES
19.3.1 BRAZIL: MARKET SIZE & FORECAST
19.3.2 MEXICO: MARKET SIZE & FORECAST
19.3.3 ARGENTINA: MARKET SIZE & FORECAST
19.3.4 COLOMBIA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
20.2.2 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
20.2.3 MIDDLE EAST & AFRICA MARKET BY APPLICATION
20.2.4 MIDDLE EAST & AFRICA MARKET BY END-USER
20.3 KEY COUNTRIES
20.3.1 TURKEY: MARKET SIZE & FORECAST
20.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
20.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST
20.3.4 UAE: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
22 MARKET SHARE ANALYSIS
22.1.1 BIO-RAD LABORATORIES
22.1.2 BIO-TECHNE
22.1.3 DANAHER
22.1.4 F. HOFFMANN LA-ROCHE
22.1.5 MERCK KGAA
22.1.6 THERMO FISHER SCIENTIFIC
23 KEY COMPANY PROFILES
23.1 BIO-RAD LABORATORIES
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 BIO-TECHNE
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 DANAHER
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 F. HOFFMANN LA-ROCHE
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
23.5 MERCK KGAA
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.5.3 KEY STRATEGIES
23.5.4 KEY STRENGTHS
23.5.5 KEY OPPORTUNITIES
23.6 THERMO FISHER SCIENTIFIC
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.6.3 KEY STRATEGIES
23.6.4 KEY STRENGTHS
23.6.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 ABCEPTA
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 ABCLONCAL
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 ABNOVA
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 ATLAS ANTIBODIES
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 AVIVA SYSTEMS BIOLOGY
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 CELL SIGNALING TECHNOLOGY
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 CANTATA BIO
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 FUJIREBIO
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 GENETEX
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 GENSCRIPT
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 ICL
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 JACKSON IMMUNORESEARCH
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 MBL INTERNATIONAL
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 OMEGA BIO-TEK
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 PROTEINTECH GROUP
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 RAYBIOTECH LIFE
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 ROCKLAND IMMUNOCHEMICALS
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 SANTA CRUZ BIOTECHNOLOGY
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 SOL GROUP
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 SOUTHERNBIOTECH
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY PRODUCT TYPE
26.1.1 NORTH AMERICA MARKET BY PRODUCT TYPE
26.1.2 EUROPE MARKET BY PRODUCT TYPE
26.1.3 APAC MARKET BY PRODUCT TYPE
26.1.4 LATIN AMERICA MARKET BY PRODUCT TYPE
26.1.5 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
26.2 MARKET BY TECHNOLOGY
26.2.1 NORTH AMERICA MARKET BY TECHNOLOGY
26.2.2 EUROPE MARKET BY TECHNOLOGY
26.2.3 APAC MARKET BY TECHNOLOGY
26.2.4 LATIN AMERICA MARKET BY TECHNOLOGY
26.2.5 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
26.3 MARKET BY APPLICATION
26.3.1 NORTH AMERICA MARKET BY APPLICATION
26.3.2 EUROPE MARKET BY APPLICATION
26.3.3 APAC MARKET BY APPLICATION
26.3.4 LATIN AMERICA MARKET BY APPLICATION
26.3.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
26.4 MARKET BY END-USER
26.4.1 NORTH AMERICA MARKET BY END-USER
26.4.3 EUROPE MARKET BY END-USER
26.4.4 APAC MARKET BY END-USER
26.4.6 LATIN AMERICA MARKET BY END-USER
26.4.7 MIDDLE EAST & AFRICA MARKET BY END-USER
26.5 MARKET BY GEOGRAPHY
26.5.1 REAGENTS MARKET BY GEOGRAPHY
26.5.2 ANTIBODY MARKET BY GEOGRAPHY
26.5.3 ELISA MARKET BY GEOGRAPHY
26.5.4 FLOW CYTOMETRY MARKET BY GEOGRAPHY
26.5.5 WESTERN BLOTTING MARKET BY GEOGRAPHY
26.5.6 IMMUNOFLUORESCENCE MARKET BY GEOGRAPHY
26.5.7 IMMUNOHISTOCHEMISTRY MARKET BY GEOGRAPHY
26.5.8 IMMUNOPRECIPITATION MARKET BY GEOGRAPHY
26.5.9 OTHER MARKET BY GEOGRAPHY
26.5.10 PROTEOMICS MARKET BY GEOGRAPHY
26.5.11 DRUG DEVELOPMENT MARKET BY GEOGRAPHY
26.5.12 GENOMICS MARKET BY GEOGRAPHY
26.5.13 ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS MARKET BY GEOGRAPHY
26.5.14 PHARMA & BIOTECH COMPANIES MARKET BY GEOGRAPHY
26.5.15 CROS & CDMOS MARKET BY GEOGRAPHY
27 APPENDIX
27.1 RESEARCH METHODOLOGY
27.2 RESEARCH PROCESS
27.3 REPORT ASSUMPTIONS & CAVEATS
27.3.1 KEY CAVEATS
27.3.2 CURRENCY CONVERSION
27.4 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the research antibodies & reagents market?
What is the growth rate of the global research antibodies & reagents market?
Which region dominates the global research antibodies & reagents market share?
What are the significant trends in the research antibodies & reagents industry?
Who are the key players in the global research antibodies & reagents market?
other RELATED Reports
Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028
Published : August 2023
Oncology Molecular Diagnostics Market – Global Outlook & Forecast 2023-2028
Published : December 2023
